Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multi-centre prophylactic concizumab trial in severe haemophilia A without inhibitors
TCTR20170512002Phase 2Not yet recruiting
- Sponsor
- Novo Nordisk
- Start
- Aug 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of concizumab in hemophilia A, sponsored by Novo Nordisk. Planned start Aug 2017; status: not yet recruiting.
02
Drugs
concizumab
03
Conditions
hemophilia A
Beyond the preview
Go deeper on TCTR20170512002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170512002.